Association of polymorphisms in angiotensin-converting enzyme and type 1 angiotensin II receptor genes with coronary heart disease and the severity of coronary artery stenosis

Abstract

To explore the relation of angiotensin-converting enzyme (ACE) and angiotensin II type 1 receptor (AT1R) gene polymorphism with coronary heart disease (CHD) and the severity of coronary artery stenosis, 130 CHD patients who underwent coronary angiography were examined for the number of affected coronary vessels (⩾75% stenosis) and coronary Jeopardy score. The insertion/deletion of ACE gene polymorphism and AT1R gene polymorphism (an A→C transversion at nucleotide position 1166) were detected by using polymerase chain reaction (PCR) and restriction fragment length polymorphism (RFLP) in CHD patients and 90 healthy serving as controls. The results showed that DD genotype and of ACE were more frequent in CHD patients than that in control group (38.5% vs 14.4%, P<0.001). The frequency of the AT1R A/C genotypes did not differ between the patients and the controls (10% vs 13.1%, P>0.05). The relative risk associated with the ACE-DD was increased by AT1R-AC genotype. Neither the number of affected coronary vessels nor the coronary score differed among the ACE I/D genotypes (P>0.05). But the number of affected coronary vessels and the coronary score were significantly greater in the patients with the AT1R-AC genotype than in those with the AA genotype (P<0.05). In conclusion, DD genotype may be risk factor for CHD and MI in Chinese people, and is not responsible for the development of the coronary artery stenosis. The AT1R-C allele may increase the relative risk associated with the ACE-DD genotype, and may be involved in the development of the stenosis of coronary artery.

Keywords

angiotensin I-converting enzyme / angiotensin II / receptor / gene polymorphism / coronary angiography

References

[1] American Heart Association.. Committee Report: a reporting system on patients evaluated for coronary artery disease. Circulation, 1975, 51(4Suppl): 5-40

[2] CallifR. M., PhillipsH. R.III, HindmanM. C., et al.. Prognostic value of a coronary artery jeopardy score. J Am Coll Cardiol, 1985, 5(5): 1055-1063

[3] RigatB., HubertC., CorvorlP., et al.. PCR detection of the inserting/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1). Nucl Acids Res, 1992, 20: 1433-1437

[4] LindpaintnerK., PfefferM. A., KreutzR., et al.. A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. N Engl J Med, 1995, 332: 706-711

[5] NakauchiY., SuehiroT., YamamotoM., et al.. Significance of angiotensin I-converting enzyme and angiotensin II type 1 receptor gene polymorphisms as risk factors for coronary heart disease. Atherosclerosis, 1996, 125: 161-169

[6] TiretL., BonnardeauxA., PoirierO., et al.. Synergistic effects of angiotensin-converting enzyme and andiotensin-II type 1 receptor gene polymorphisms on risk of myocardial infarction. Lancet, 1994, 344(8927): 910-913

[7] GardemannA., NguyenQ. D., HummeJ.. Angiotensin II type 1 receptor A1166c gene polymorphism. Absence of an association with the risk of coronary artery disease and myocardial infarction and of a synergistic effect with angiotensin-converting enzyme gene polymorphism on the risk of these diseases. Eur Heart J, 1998, 19(11): 1657-1665

[8] HernandezO. E., MedinaF. A., RodriguezE. F. J., et al.. The involvement of rennin angiotensin system gene polymorphism in coronary heart disease. Rev Esp Cardiol, 2002, 55(2): 92-99

[9] PengJ., PengS., GongW. X.. Association between early-onset coronary heart disease and angiotensin II type 1 receptor gene polymorphism. Natl Med J China (Chinese), 2002, 82: 471-473

[10] StanglK., CascorbiI., StanglV., et al.. A1166/C polymorphism of the angiotensin II type 1 receptor gene and risk of adverse events after coronary catheter intervertion. Am Heart J, 2000, 140(1): 170-175